KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $120.8 million.

  • West Pharmaceutical Services' Gains from Investment Securities rose 15062.24% to $120.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $125.2 million, marking a year-over-year increase of 7609.0%. This contributed to the annual value of $125.2 million for FY2025, which is 7535.01% up from last year.
  • West Pharmaceutical Services' Gains from Investment Securities amounted to $120.8 million in Q4 2025, which was up 15062.24% from -$2.5 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Gains from Investment Securities peaked at $174.1 million during Q3 2021, and registered a low of -$16.7 million during Q4 2021.
  • Its 5-year average for Gains from Investment Securities is $35.2 million, with a median of $12.6 million in 2021.
  • Data for West Pharmaceutical Services' Gains from Investment Securities shows a peak YoY increase of 926315.79% (in 2021) and a maximum YoY decrease of 17260.87% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Gains from Investment Securities stood at -$16.7 million in 2021, then skyrocketed by 640.72% to $90.3 million in 2022, then decreased by 14.4% to $77.3 million in 2023, then plummeted by 37.65% to $48.2 million in 2024, then surged by 150.62% to $120.8 million in 2025.
  • Its Gains from Investment Securities was $120.8 million in Q4 2025, compared to -$2.5 million in Q3 2025 and $4.0 million in Q2 2025.